SKI Market

Indian Indices

Sensex

84,679.86 -533.50
( -0.63%)

Global Indices

Nasdaq

48,441.87 -37.19
(-0.08%)

Dow Jones

6,837.99 -10.42
(-0.15%)

Hang Seng

49,445.34 -722.77
(-1.44%)

Nikkei 225

9,668.67 -82.64
(-0.85%)

Forex

USD-INR

90.53 0.34
(0.38%)

EUR-INR

106.28 0.58
(0.55%)

GBP-INR

121.02 0.27
(0.22%)

JPY-INR

0.58 0.00
(0.23%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Novelix Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

536565

INE314I01036

23.5671906

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

117.48

113.88

EPS(TTM)

Face Value()

Div & Yield %

0.52

Back

Bright Brothers consolidated net profit rises 28.34% in the June 2025 quarter

Aug 12,2025

Net profit of Bright Brothers rose 28.34% to Rs 3.17 crore in the quarter ended June 2025 as against Rs 2.47 crore during the previous quarter ended June 2024. Sales rose 21.53% to Rs 101.08 crore in the quarter ended June 2025 as against Rs 83.17 crore during the previous quarter ended June 2024.

Particulars	Quarter Ended
	Jun. 2025	Jun. 2024	% Var.
Sales	101.08	83.17	22
OPM %	8.15	8.10	-
PBDT	6.26	5.20	20
PBT	3.46	2.77	25
NP	3.17	2.47	28

84,679.86 -533.50 ( -0.63%)

48,441.87 -37.19 (-0.08%)

6,837.99 -10.42 (-0.15%)

49,445.34 -722.77 (-1.44%)

9,668.67 -82.64 (-0.85%)

90.53 0.34 (0.38%)

106.28 0.58 (0.55%)

121.02 0.27 (0.22%)

0.58 0.00 (0.23%)